Loading clinical trials...
Loading clinical trials...
Emotionally labile, depressed participants with multiple sclerosis treated with escitalopram will have a greater reduction in emotional lability scores and in their psychological distress scores than ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Weill Medical College of Cornell University
Collaborators
NCT05837104 · Bipolar I Disorder, Depression, Anxiety, and more
NCT07189325 · Relapsing-Remitting Multiple Sclerosis (RRMS), Anti-CD20 Therapy
NCT06833788 · Postpartum Depression (PPD)
NCT07663266 · Multiple Sclerosis, Spinal Cord Injury
NCT06085950 · Treatment Resistant Depression
NewYork Presbyterian Hospital
White Plains, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions